Quick Overview: Ashley Boam and Jennifer Maguire discuss audience questions. Learn more at: ... Jeffery Summers and Marc Theoret discuss audience questions. Presenters: Jeffery Summers, MD, associate director, ... Howard Chazin, Linda Forsyth, Lauren Gilles, Niles Ron, and Debra Catterson discuss audience questions. Presenters: Howard ...

Industry Panel Insights On Fda - Detailed Overview & Context

Ashley Boam and Jennifer Maguire discuss audience questions. Learn more at: ... Jeffery Summers and Marc Theoret discuss audience questions. Presenters: Jeffery Summers, MD, associate director, ... Howard Chazin, Linda Forsyth, Lauren Gilles, Niles Ron, and Debra Catterson discuss audience questions. Presenters: Howard ... Lakeeta Carr, Nicholas Daniel, LCDR Cassandra Metu and Heidi Lee discuss audience questions. Learn more at: ... Panelists at the Stanford Think Tank on Diversity and Health Equity in Clinical Trials share their expertise on improving healthcare ... Presenters respond to audience questions on complex generic drug-device combination products and complex abuse deterrent ...

Thomas O'Connor, Changning Gou, Patricia Onyimba, Shin (Grace) Chou, Kshitij (Kris) Patkar and Melanie Mueller discuss ... Sarah Ibrahim, Nilufer Tampal, Makini Cobourne-Duval, and Victoria Keck discuss audience questions. Learn more at: ... Bijal Patel, Nnenna Nzelibe, Charlene Peterson, CDR Eunjung Esther Chuh, and Julia Lee discuss audience questions. Tao Bai, Cassie Abellard, and Jonathan Swoboda discuss audience questions. Presenters: Tao Bai, PhD Office of Bioequivalence ... Good Clinical Practice & Pharmacovigilance Compliance Symposium In this session, all speakers come together for a productive and informative Q&A discussion. ***No Timestamps*** Panelists: ...

Robert Lionberger, PhD, Director, Office of Research and Standards, Office of Generic Drugs, Rakhi Shah, Mahesh Ramanadham, Derek Smith, and Zhihao Peter Qiu respond to audience questions.

Photo Gallery

Industry Panel Insights on FDA's Guidance and Inclusive Clinical Trials
FDA & Industry Panel Discussion: Biomanufacturing Innovation in a Regulated Industry
Panel Discussion
Panel Discussion
Mastering the FDA 510(k) Submission Process: A Practical Guide
Panel Discussion
Panel Discussion
Diversity and Health Equity in Clinical Trials: Expert Panel Insights
Panel Discussion (31of39) Complex Generics 2018
Panel Discussion
Panel Discussion
Breaking Down My FDA Panel Statement on SSRIs and Media Backlash | Radically Genuine | Ep. 195
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored